Christophe Picard - Concepedia

Author

Christophe Picard

Centre National de la Recherche Scientifique ORCID

Also Known As

Boris Calmels, C Picard, C W Picard, C. PICARD, C. Picard, Christophe Picard, Picard, C., Picard, Christophe

228

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Aix-Marseille Université Inserm Établissement Français du Sang Institut Paoli-Calmettes

About

Christophe Picard is an author at Centre National de la Recherche Scientifique specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	781
2	Health Sciences	3	3	160
3	Public Health	3	3	145
4	Engineering	2	2	41
5	Allergy	1	1	44

Christophe Picard

Publications

Citations

H-Index

Page 1

	Year	Citations
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study Jens Kühle, Giulio Disanto, Ruth Dobson, Multiple Sclerosis Journal	2015	290
Immune diversity sheds light on missing variation in worldwide genetic diversity panels Laurent Abi‐Rached, Philippe Gouret, Jung-Hua Yeh, PLoS ONE Hla DiversityGeneticsImmunologyGenetic EpidemiologyHuman Polymorphism	2018	91
Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor Didier Blaise, Sabine Fürst, Roberto Crocchiolo, Biology of Blood and Marrow Transplantation	2015	88
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection L. Perrot, Marie F. Hemon, Jean‐Marc Busnel, The Lancet Rheumatology Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesImmunology	2020	84
Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children C. Rénard, Vincent Barlogis, Valérie Mialou, British Journal of Haematology Cell TherapyBone Marrow TransplantImmunologyTransplantation MedicineMedian Time	2010	74
Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia Mélanie Bonnet, Marie Loosveld, Bertrand Montpellier, Blood	2011	74
HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis Nathalie Balandraud, Christophe Picard, D Reviron, PLoS ONE	2013	72
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study Norbert Vey, Xavier Thomas, Christophe Picard, Leukemia Hematological MalignancyTransplantationMarrow TransplantationMixed-phenotype Acute LeukemiaStem Cell Transplantation	2006	71
Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI Thomas Cluzeau, Jérôme Lambert, Nicole Raus, Bone Marrow Transplantation TransplantationMarrow TransplantationStem Cell TransplantationHematologyGraft Failure	2016	69
The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein Ghérici Hassaı̈ne, M Courcoul, Gilles Bessou, Journal of Biological Chemistry Viral ReplicationTyrosine KinaseImmunologyHiv-1 Replication CounteractedAntiviral Drug	2001	59

Page 1